200 related articles for article (PubMed ID: 21903576)
1. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
Guo LW; Gao L; Rothschild J; Su B; Gelman IH
J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
[TBL] [Abstract][Full Text] [Related]
2. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
Su B; Bu Y; Engelberg D; Gelman IH
J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
[TBL] [Abstract][Full Text] [Related]
3. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
[TBL] [Abstract][Full Text] [Related]
4. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture.
Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH
J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468
[TBL] [Abstract][Full Text] [Related]
5. Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.
Ko HK; Guo LW; Su B; Gao L; Gelman IH
PLoS One; 2014; 9(10):e111534. PubMed ID: 25356636
[TBL] [Abstract][Full Text] [Related]
6. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.
Gelman IH; Lee K; Tombler E; Gordon R; Lin X
Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.
Lin X; Gelman IH
Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.
Gelman IH
Cancer Metastasis Rev; 2012 Dec; 31(3-4):493-500. PubMed ID: 22684366
[TBL] [Abstract][Full Text] [Related]
9. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.
Lin X; Nelson P; Gelman IH
Mol Cell Biol; 2000 Oct; 20(19):7259-72. PubMed ID: 10982843
[TBL] [Abstract][Full Text] [Related]
10. Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/AKAP12 metastasis suppressor correlate with FAK upregulation.
Akakura S; Bouchard R; Bshara W; Morrison C; Gelman IH
Int J Cancer; 2011 Oct; 129(8):2025-31. PubMed ID: 21128249
[TBL] [Abstract][Full Text] [Related]
11. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.
Gelman IH; Tombler E; Vargas J
Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381
[TBL] [Abstract][Full Text] [Related]
12. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.
Akakura S; Nochajski P; Gao L; Sotomayor P; Matsui S; Gelman IH
Cell Cycle; 2010 Dec; 9(23):4656-65. PubMed ID: 21099353
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.
Xia W; Gelman IH
Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796
[TBL] [Abstract][Full Text] [Related]
14. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells.
Nelson PJ; Moissoglu K; Vargas J; Klotman PE; Gelman IH
J Cell Sci; 1999 Feb; 112 ( Pt 3)():361-70. PubMed ID: 9885289
[TBL] [Abstract][Full Text] [Related]
16. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .
Gelman IH
Front Biosci; 2002 Aug; 7():d1782-97. PubMed ID: 12133808
[TBL] [Abstract][Full Text] [Related]
17. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.
Akakura S; Huang C; Nelson PJ; Foster B; Gelman IH
Cancer Res; 2008 Jul; 68(13):5096-103. PubMed ID: 18593908
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated Ca2+ and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin.
Schott MB; Grove B
Cell Signal; 2013 Nov; 25(11):2125-35. PubMed ID: 23838009
[TBL] [Abstract][Full Text] [Related]
19. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
Gelman IH; Gao L
Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
[TBL] [Abstract][Full Text] [Related]
20. Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling.
Akakura S; Gelman IH
J Signal Transduct; 2012; 2012():529179. PubMed ID: 22811901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]